Emerging Nanomaterial-Based Medications: Key Challenges and Opportunities

Abstract

Nanomaterial-based medications have a wealth of potential innovative clinical applications, representing possible solutions for long-standing clinical challenges whether considering congenital or acquired diseases. Effective translation into practice depends on a focused, ethically aware and cooperative approach to the development, characterization and assessment of the novel developed materials. For crossing the bridge between the lab and the patients in need of solutions, either human or animal, it is as important to understand the unique challenges posed as it is foreseeing the future applications.